Phenobarbital Sodium Patent Expiration
Phenobarbital Sodium is used for treating neonatal seizures. It was first introduced by Sun Pharmaceutical Industries Inc
Phenobarbital Sodium Patents
Given below is the list of patents protecting Phenobarbital Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sezaby | US11857683 | Stabilization of phenobarbital sodium for injection | Apr 07, 2042 | Sun Pharm Inds Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Phenobarbital Sodium's patents.
Latest Legal Activities on Phenobarbital Sodium's Patents
Given below is the list recent legal activities going on the following patents of Phenobarbital Sodium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eGrant Notification | 02 Jan, 2024 | US11857683 |
| Mail Patent eGrant Notification | 02 Jan, 2024 | US11857683 |
| Email Notification Critical | 02 Jan, 2024 | US11857683 |
| Recordation of Patent Grant Mailed Critical | 02 Jan, 2024 | US11857683 |
| Recordation of Patent eGrant | 02 Jan, 2024 | US11857683 |
| Patent Issue Date Used in PTA Calculation Critical | 02 Jan, 2024 | US11857683 |
| Email Notification Critical | 14 Dec, 2023 | US11857683 |
| Issue Notification Mailed Critical | 13 Dec, 2023 | US11857683 |
| Application Is Considered Ready for Issue Critical | 29 Nov, 2023 | US11857683 |
| Dispatch to FDC | 29 Nov, 2023 | US11857683 |
Phenobarbital Sodium's Family Patents
